MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

EnteroMedics Company Profile (NASDAQ:ETRM)

Consensus Ratings for EnteroMedics (NASDAQ:ETRM) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.75 (1,668.87% upside)

Analysts' Ratings History for EnteroMedics (NASDAQ:ETRM)
Show:
DateFirmActionRatingPrice TargetActions
11/13/2015Roth CapitalLower Price TargetBuy$18.75 -> $11.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Canaccord GenuityLower Price Target$37.50 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Canaccord GenuityReiterated RatingBuy$37.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Roth CapitalLower Price TargetBuy$33.75 -> $18.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Canaccord GenuityReiterated RatingBuy$60.00 -> $37.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Craig HallumLower Price TargetBuy$75.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Canaccord GenuitySet Price TargetBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Roth CapitalSet Price TargetBuy$33.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2015Canaccord GenuitySet Price TargetBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2014Roth CapitalBoost Price TargetBuy$45.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2014Canaccord GenuityBoost Price TargetBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2014Canaccord GenuityLower Price Target$90.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Northland SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/14/2014Canaccord GenuityBoost Price Target$45.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha